期刊文献+

辐射损伤防治药物研究进展

Research progress of irradiation injuries anti-agents
原文传递
导出
摘要 辐射损伤防治药物是指能抑制辐射损伤的发生,或者在照射后早期使用减轻辐射损伤的发展,促进损伤恢复的药物。根据作用机制和干预时间,将辐射损伤的防治药物分为4类,即外辐射暴露的防护药、缓解药、治疗药以及放射性核素内污染防治药。本文对近年来辐射损伤防治药的研究进展进行综述。 Irradiation injuries anti-agents refer to drugs that can inhibit the initial stage of radiation injuries,or reduce the development of radiation injuries and promote the recovery of injuries when used early after irradiation exposure.According to the mechanism of action and the time of intervention,the irradiation injuries anti-agents are divided into four categories:radioprotectors,radiomitigators,radiation therapeutics for external radiation exposure,and anti-agents for internalized radionuclides.In this paper,the research progress of irradiation injuries anti-agents in recent years is reviewed.
作者 杜亚南 杨雪莹 曾强 Du Yanan;Yang Xueying;Zeng Qiang(Institute for Occupational Health,Tianjin Centers for Disease Control and Prevention,Tianjin 300011,China)
出处 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2023年第3期237-240,共4页 Chinese Journal of Industrial Hygiene and Occupational Diseases
基金 天津市医学重点学科(专科)建设项目(TJYXZDXK-066B) 天津市卫生健康科研项目(TJWJ2022XK040)。
关键词 辐射 电离 辐射损伤 辐射防护剂 辐射损伤缓解药 辐射损伤治疗药 放射性核素内污染防治药 Radiation,ionizing Radiation injuries Radiation-protective agents Radiomitigators Radiation therapeutics Anti-agents for internalized radionuclides
  • 相关文献

参考文献4

二级参考文献75

  • 1Vasin M V. Comments on the mechanisms of action of radiation protective agents: basis components and their polyvalence [J]. Springer Plus, 2014, 3: 414. DOI: 10.1186/2193-1801-3-414. eCollection 2014. 被引量:1
  • 2Rosen E M, Day R, Singh V K. New approaches to radiation protection [J]. Frontiers in Oncolgy, 2015, 4: 381. DOI: 10.3389/fone.2014.00381. 被引量:1
  • 3Singh P K, Wise S Y, Ducey E J, et al. Alpha- tocopherolsuccinate protects mice against radiation- induced gastrointestinal injury [J]. Radiation Research, 2012, 177(2): 133-145. 被引量:1
  • 4Feng M, Smith D E, Normolle D P, et al. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy [J]. International Journal of Radiation Oncology, Biology, Physics, 2012, 83(5): 1441-1447. 被引量:1
  • 5Koukourakis M I, Panteliadou M, Abatzoglou I M, et al. A Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection [J]. International Journal of Radiation Oncology, Biology, Physics, 2013, 85(l): e7-e13. 被引量:1
  • 6Duval M, Daniel S J. Meta-analysis of the efficacy of amifostine in the prevention of cisplatinototoxicity [J]. Journal of Otolaryngology Head and Neck Surgery, 2012, 41(5): 309-315. 被引量:1
  • 7Nicolatou-galitis O, Sarri T, Bowen J, et al. Systematic review of amifostine for them anagement of oral mucositis in cancer patients [J]. Supportive Care in Cancer, 2013, 21(1): 357-364. 被引量:1
  • 8Seed T M, Inal C E, Singh V K. Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis [J]. International Journal of Radiation Biology, 2014, 90(7): 594-604. 被引量:1
  • 9Copp R R, Peebles D D, Soref C M, et al. Radioprotective efficacy and toxicity of a new family of aminothiol analogs [J]. International Journal of Radiation Biology, 2013, 89(7): 485- 492. 被引量:1
  • 10Gerondakis S, Fulford T S, Messina N L, et al. NF-v,B control of T cell development [J]. Nature Immunology, 2014, 15(1): 15-25. 被引量:1

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部